Powerpack

Unlock full stockrow access for only $9.90/month and boost yourself as an investor.

  • Full quarterly history

    Every quarter and TTM period we hold, not just the last 12.

  • Analyst estimates

    Three years of forward estimates and dividend forecasts.

  • Unlimited screener

    All results, unlimited saved screens, email when a screen changes.

  • Unlimited Excel

    Full workbooks and screener exports.

  • Unlimited follows

See Powerpack
Screener Weekly Summary Pricing

Vertex Pharmaceuticals Incorporated VRTX

Healthcare  —  Biotechnology
526.19 3.81 0.73% as of 25 Sep
Market cap
$132.3B
P/E
30.4×
S&P 500 Member Revenue Champion (10y)
Indexes indicate stock being part of an index,
Growth Flags show if company had growth for consecutive years
Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K

Vertex Pharmaceuticals Incorporated (VRTX) Price to free cash flow

As of 25 September 2026, Vertex Pharmaceuticals Incorporated (VRTX) trades at a price to free cash flow of 35.2×. Over the past ten years it has ranged from 0.0× (June 2025) to 353× (November 2016); the current reading is higher than 70% of that period. That is above the Biotechnology industry median of 21.2× and above the Healthcare sector median of 19.5×.

Price to free cash flow, daily

Annual

Period Price to free cash flow Change
FY2025 36.3× —
FY2024 0.0× —
FY2023 31.7× 70.05%
FY2022 18.7× (20.58%)
FY2021 23.5× 14.56%
FY2020 20.5× (45.48%)
FY2019 37.6× 4.89%
FY2018 35.9× (29.73%)
FY2017 51.0× (49.99%)
FY2016 102× —

Quarterly

Period Price to free cash flow Change
Jun 2026 33.2× 8.55%
Mar 2026 30.6× (15.75%)
Dec 2025 36.3× 21.00%
Sep 2025 30.0× (8.14%)
42 more quarters

Against its own ten years

Low 0.0× High 353×
Ten-year median 28.2×
Current reading's percentile 70

Price to free cash flow against peers

Company Price to free cash flow
INSM Insmed, Inc. compare n/m
RVMD Revolution Medicines, Inc. compare n/m
MRNA Moderna, Inc. compare n/m
RPRX Royalty Pharma PLC compare 19.8×
REGN Regeneron Pharmaceuticals, Inc. compare 22.7×
ONC BeOne Medicines Ltd. - Sponsored ADR compare 30.7×
VRTX Vertex Pharmaceuticals Incorporated 35.2×
ALNY Alnylam Pharmaceuticals, Inc. compare 41.7×
ARGX argenex SE compare 43.4×
Biotechnology industry median 21.2×
Healthcare sector median 19.5×
Market median 14.0×

What Price to free cash flow is

Price to Free Cash Flow Ratio shows how much investors pay for each dollar of cash a company generates after its capital spending.

Stock Price ÷ ((Operating Cash Flow (TTM) + Property, Plant, Equipment Change (Net) (TTM) + Intangible Assets Change (Net) (TTM)) ÷ (Shares (Basic, Weighted) (latest quarter)))

The full definition of Price to free cash flow →

More on VRTX